U.S. markets are navigating a complex landscape of new tariffs, a thriving AI sector, and revised economic data, creating investor uncertainty. Peter Cardillo suggests the announced pharmaceutical tariffs are a negotiation tactic, while AI continues to attract significant investment. He cautions against overemphasizing strong GDP figures, citing unusual trade flows, and highlights inflation as a key market driver.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets